• Company Information
  • Press Releases
  • Events & Presentations
  • Management Team
  • FAQ's
• Corporate Governance
  • Documents & Charters
  • Board of Directors
  • Committee Composition
• Financial Information
  • Quarterly Results
  • Financial Releases
  • Annual Reports
  • SEC Filings
  • Fundamentals
  • Historical Financial Data
• Stock Information
  • Stock Quote & Chart
  • Stock Calculator
  • Historic Price Lookup
  • Analyst Coverage

The Invisalign system and iTero and iOC intra-oral scanning systems and OrthoCAD digital services are available to general practitioner dentists (GP dentists), orthodontists, and other dental specialists. Align provides training, clinical education programs, and the tools needed for orthodontists or GP dentists to adopt its innovative technology and offer the treatment options in their practices.

Firm	Analyst	Address
Barrington Research Associates	Michael L. Ruggirello	161 N. Clark Street Suite 2950 Chicago, IL 60601
Brigantine Advisors	Robert M. Gold	780 Third Avenue New York, NY 10017
JMP Securities L.L.C.	Jose Haresco	The Pyramid Center 600 Montgomery Street, Suite 1100 San Francisco, CA 94111
Madison Williams and Company	Spencer H. Nam	245 First Street Suite 1846 Cambridge, MA 02142
Northcoast Research	Ed Snyder	1001 Lakeside Ave. Suite 1500 Cleveland, OH 44114
Roth Capital Partners	Matt Dolan	24 Corporate Plaza Drive Newport Beach, CA 92660
Standard & Poor's	Phillip Seligman	55 Water Street New York, NY 10041
Stephens, Inc.	Christopher Cooley	111 Center Street Little Rock, AR 72201
SunTrust Robinson Humphrey	Jonathan Block	711 5th Ave. New York, NY 10022
Susquehanna International Group, LLP	David Turkaly	40 Wall Street New York, NY 10005

Align Technology, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Align Technology, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Align Technology, Inc. or its management. Align Technology, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.